Cite
HARVARD Citation
Platzbecker, U. et al. (n.d.). Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study. Lancet oncology. 18 (10), pp. 1338-1347. [Online].